ES2690412R1 - Procedimiento para la obtención de secoiridoides dialdehídicos - Google Patents

Procedimiento para la obtención de secoiridoides dialdehídicos

Info

Publication number
ES2690412R1
ES2690412R1 ES201700241A ES201700241A ES2690412R1 ES 2690412 R1 ES2690412 R1 ES 2690412R1 ES 201700241 A ES201700241 A ES 201700241A ES 201700241 A ES201700241 A ES 201700241A ES 2690412 R1 ES2690412 R1 ES 2690412R1
Authority
ES
Spain
Prior art keywords
secoiridoids
procedure
dialdehyde
obtaining
obtaining dialdehyde
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201700241A
Other languages
English (en)
Other versions
ES2690412A2 (es
ES2690412B1 (es
Inventor
Guzman José María Fernandez-Bolanos
Castilla Inés Maya
Benjumea Alejandro Gonzalez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad de Sevilla
Original Assignee
Universidad de Sevilla
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad de Sevilla filed Critical Universidad de Sevilla
Priority to ES201700241A priority Critical patent/ES2690412B1/es
Priority to PCT/ES2018/000016 priority patent/WO2018162769A2/es
Priority to EP18764100.6A priority patent/EP3594198A4/en
Publication of ES2690412A2 publication Critical patent/ES2690412A2/es
Publication of ES2690412R1 publication Critical patent/ES2690412R1/es
Application granted granted Critical
Publication of ES2690412B1 publication Critical patent/ES2690412B1/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/317Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • C07C67/327Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups by elimination of functional groups containing oxygen only in singly bound form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/01Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01003Triacylglycerol lipase (3.1.1.3)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10General cosmetic use

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
ES201700241A 2017-03-10 2017-03-10 Procedimiento para la obtención de secoiridoides dialdehídicos Active ES2690412B1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ES201700241A ES2690412B1 (es) 2017-03-10 2017-03-10 Procedimiento para la obtención de secoiridoides dialdehídicos
PCT/ES2018/000016 WO2018162769A2 (es) 2017-03-10 2018-03-09 Uso del dmso para la síntesis de oleaceína y oleocantal
EP18764100.6A EP3594198A4 (en) 2017-03-10 2018-03-09 USE OF DMSO IN THE SYNTHESIS OF OLEACEIN AND OLEOCANTHAL

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201700241A ES2690412B1 (es) 2017-03-10 2017-03-10 Procedimiento para la obtención de secoiridoides dialdehídicos

Publications (3)

Publication Number Publication Date
ES2690412A2 ES2690412A2 (es) 2018-11-20
ES2690412R1 true ES2690412R1 (es) 2019-02-08
ES2690412B1 ES2690412B1 (es) 2019-11-13

Family

ID=63449030

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201700241A Active ES2690412B1 (es) 2017-03-10 2017-03-10 Procedimiento para la obtención de secoiridoides dialdehídicos

Country Status (3)

Country Link
EP (1) EP3594198A4 (es)
ES (1) ES2690412B1 (es)
WO (1) WO2018162769A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2769902B2 (es) * 2018-12-28 2020-12-04 Consejo Superior Investigacion Uso de secoiridoides para el tratamiento de la neuritis óptica.
EP3838885B1 (en) * 2019-12-16 2022-06-29 National and Kapodistrian University of Athens Process for the production of oleocanthal, oleacein and their analogues

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007081808A2 (en) * 2006-01-05 2007-07-19 Deviris Inc. Compounds and derivatives for the treatment of medical conditions by modulating hormone-sensitive lipase activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006122128A2 (en) 2005-05-09 2006-11-16 The Trustees Of The University Of Pennsylvania Use of the irritating principal oleocanthal in olive oil, as well as structurally and functionally similar compounds
US20130115202A1 (en) 2005-08-31 2013-05-09 Theta Biomedical Consulting & Development Co., Inc Anti-inflammatory compositions for treating neuro-inflammation
PL227843B1 (pl) 2012-07-14 2018-01-31 Warszawski Uniwersytet Medyczny Zastosowanie Ligustrum vulgare L. do wytwarzania preparatu zawierającego oleaceinę

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007081808A2 (en) * 2006-01-05 2007-07-19 Deviris Inc. Compounds and derivatives for the treatment of medical conditions by modulating hormone-sensitive lipase activity

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JERMAN KLEN, T. et al. . PHENOLIC PROFILING OF OLIVES AND OLIVE OIL PROCESS-DERIVED MATRICES USING UPLC-DAD-ESI-QTOF-HRMS ANALYSIS. Journal of Agricultural and Food Chemistry, 18.03.2015, Vol. 63, Nº 15, Páginas 3859-3872 0021-8561, (DOI: 10.1021/jf506345q) Ver página 3859; página 3865, tabla 3, estructura II. *
MASON, J.D. & MURPHREE, S.S. . MICROWAVE-ASSISTED AQUEOUS KRAPCHO DECARBOXYLATION. Synlett, 08.05.2013, Vol. 24, Nº 11, Páginas 1391-1394 1437-2096, (DOI: 10.1055/s-0033-1338701) Ver página 1391, resumen y columna 1, párrafo 1; esquemas 1 y 2. *
MONTEDORO, G. et al. . SIMPLE AND HYDROLYZABLE COMPOUNDS IN VIRGIN OLIVE OIL. 3. SPECTROSCOPIC CHARACTERIZATIONS OF THE SECOIRIDOID DERIVATIVES. Journal of Agricultural and Food Chemistry, 1993, Vol. 63, Nº 15, Páginas 2228-2234 0021-8561, (DOI: 10.1021/jf00035a076) Ver página 2228, resumen; página 2231, figura 3. *
VOUGOGIANNOPOULOU, K. at al. . ONE-STEP SEMISYNTHESIS OF OLEACEIN AND THE DETERMINATION AS A 5-LIPOXYGENASE INHIBITOR. Journal of Natural Products , 25.02.2014, Vol. 77, Nº 3, Páginas 441-445 0163-3864, (DOI: 10.1021/np401010x) Ver página 441, resumen; página 442, columna 2, párrafos 3-4; figura 2; página 444, columna 2, párrafo 1. *

Also Published As

Publication number Publication date
WO2018162769A2 (es) 2018-09-13
EP3594198A2 (en) 2020-01-15
WO2018162769A3 (es) 2018-11-08
EP3594198A4 (en) 2021-09-08
ES2690412A2 (es) 2018-11-20
ES2690412B1 (es) 2019-11-13

Similar Documents

Publication Publication Date Title
BR112017027764A2 (pt) melhorias de medição para sistemas lte
CL2017002628S1 (es) Máquina de afeitar
DK3600456T3 (da) Fremgangsmåde til sterilisering
MA45277A (fr) Promédicaments de pth
BR112016022868A2 (pt) método para preparação de amg 416.
CL2017002779S1 (es) Máquina de afeitar
MA46280A (fr) Inhibiteurs de la dopamine-b-hydroxylase
ES2690412R1 (es) Procedimiento para la obtención de secoiridoides dialdehídicos
DK3237603T3 (da) Fremgangsmåde til adaptering
ES2693177R1 (es) Procedimiento para la obtención de secoiridoides dialdehídicos
ITUA20161889A1 (it) Coltello
ES1153384Y (es) Soporte para mancuernas
ES1145533Y (es) Estructura para la mimetizacion de antenas
ES1135628Y (es) Monoboya para vertido controlado
ES1199310Y (es) Conjunto para teleconsulta
UA37486S (uk) Опакування - етикетка для міні-круасанів
ES1180434Y (es) Montura para prismaticos
ES1169383Y (es) Senuelo para la pesca
FI11965U1 (fi) Laitteisto pilkkeiden valmistamiseksi
ES1192658Y (es) Aguja para la elaboración de rastas
ES1184289Y (es) Soporte para la realizacion de manualidades
ES2697706R1 (es) Proceso Para La Preparación De Galeterona.
ES1170758Y (es) Dispositivo para la obtención de combinaciones alfanuméricas
ES1187088Y (es) Calzado para condiciones adversas
ES1198133Y (es) Elemento de acople rapido para construccion de altillos

Legal Events

Date Code Title Description
BA2A Patent application published

Ref document number: 2690412

Country of ref document: ES

Kind code of ref document: A2

Effective date: 20181120

EC2A Search report published

Ref document number: 2690412

Country of ref document: ES

Kind code of ref document: R1

Effective date: 20190201

FG2A Definitive protection

Ref document number: 2690412

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20191113